Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.15%316.97M | -3.21%661.65M | -8.04%298.6M | -6.14%683.59M | -17.35%324.72M | -15.67%728.31M | 6.34%392.9M | 31.79%863.62M | 33.04%369.46M | 13.01%655.32M |
| Operating income | 6.15%316.97M | -3.21%661.65M | -8.04%298.6M | -6.14%683.59M | -17.35%324.72M | -15.67%728.31M | 6.34%392.9M | 31.79%863.62M | 33.04%369.46M | 13.01%655.32M |
| Cost of sales | -6.76%-257.74M | 5.82%-536.03M | 11.74%-241.43M | 6.26%-569.13M | 17.61%-273.54M | 14.84%-607.14M | -10.68%-332.01M | -30.15%-712.98M | -25.98%-299.98M | -14.21%-547.79M |
| Operating expenses | -6.76%-257.74M | 5.82%-536.03M | 11.74%-241.43M | 6.26%-569.13M | 17.61%-273.54M | 14.84%-607.14M | -10.68%-332.01M | -30.15%-712.98M | -25.98%-299.98M | -14.21%-547.79M |
| Gross profit | 3.59%59.22M | 9.75%125.62M | 11.69%57.17M | -5.54%114.46M | -15.95%51.19M | -19.56%121.17M | -12.36%60.9M | 40.10%150.64M | 75.49%69.48M | 7.26%107.52M |
| Selling expenses | -6.38%-13.6M | 17.53%-24.37M | 16.90%-12.78M | -24.54%-29.55M | -16.67%-15.38M | 20.07%-23.73M | 20.40%-13.18M | 4.16%-29.69M | -31.13%-16.56M | -2.07%-30.98M |
| Administrative expenses | -1.25%-19.84M | 12.68%-40.55M | 12.94%-19.6M | -18.21%-46.44M | -12.36%-22.51M | -6.23%-39.28M | -12.33%-20.03M | -9.34%-36.98M | -5.60%-17.83M | -1.98%-33.82M |
| Impairment and provision | ---- | 99.39%-67K | ---- | -3,025.99%-11.03M | ---- | --377K | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | 99.39%-67K | ---- | -3,025.99%-11.03M | ---- | --377K | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 37.34%-297K | -41.18%-1.06M | -108.81%-474K | ---748K |
| Special items of operating profit | 137.63%257K | -134.11%-993K | -163.65%-683K | 50.83%2.91M | -27.84%1.07M | -89.89%1.93M | -91.05%1.49M | 159.43%19.09M | 742.60%16.62M | 56.97%7.36M |
| Operating profit | 8.02%26.04M | 96.49%59.64M | 67.79%24.11M | -49.80%30.35M | -50.24%14.37M | -40.72%60.46M | -43.64%28.87M | 106.75%102M | 333.44%51.23M | 19.11%49.34M |
| Financing cost | 20.29%-275K | 49.55%-677K | 47.09%-345K | -141.80%-1.34M | ---652K | ---555K | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | -11.68%2.53M | 32.38%2.31M | -48.44%2.87M | -27.72%1.74M | -10.88%5.56M | -46.87%2.41M | --6.24M | --4.54M | ---- |
| Earning before tax | -1.16%25.77M | 92.91%61.5M | 68.64%26.07M | -51.31%31.88M | -50.59%15.46M | -39.52%65.47M | -43.90%31.28M | 119.40%108.24M | 371.82%55.76M | 20.17%49.34M |
| Tax | -13.23%-8.07M | -53.26%-17.81M | -45.86%-7.13M | 34.74%-11.62M | 34.85%-4.89M | 19.72%-17.81M | 40.88%-7.5M | -53.63%-22.18M | -259.71%-12.69M | -30.62%-14.44M |
| After-tax profit from continuing operations | -6.57%17.69M | 115.66%43.69M | 79.18%18.94M | -57.50%20.26M | -55.55%10.57M | -44.62%47.66M | -44.80%23.78M | 146.61%86.06M | 419.50%43.08M | 16.32%34.9M |
| Earning after tax | -6.57%17.69M | 115.66%43.69M | 79.18%18.94M | -57.50%20.26M | -55.55%10.57M | -44.62%47.66M | -44.80%23.78M | 146.61%86.06M | 419.50%43.08M | 16.32%34.9M |
| Profit attributable to shareholders | -6.57%17.69M | 115.66%43.69M | 79.18%18.94M | -57.50%20.26M | -55.55%10.57M | -44.62%47.66M | -44.80%23.78M | 146.61%86.06M | 419.50%43.08M | 16.32%34.9M |
| Basic earnings per share | 0.00%0.03 | 100.00%0.06 | 50.00%0.03 | -57.14%0.03 | -33.33%0.02 | -46.15%0.07 | -50.00%0.03 | 160.00%0.13 | 500.00%0.06 | 25.00%0.05 |
| Diluted earnings per share | 0.00%0.03 | 100.00%0.06 | 50.00%0.03 | -57.14%0.03 | -33.33%0.02 | -46.15%0.07 | -50.00%0.03 | 160.00%0.13 | 500.00%0.06 | 25.00%0.05 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.